GALAXI 2 & 3: Guselkumab proves efficacy in Crohn’s disease Presented ByDr Remo Panaccione, University of Calgary, Canada TrialGALAXI ConferenceDDW 2024 TypePeer-reviewed article 11 July 2024 13:01